Skip to main content
. Author manuscript; available in PMC: 2014 Apr 24.
Published in final edited form as: Aliment Pharmacol Ther. 2012 Oct 14;36(0):1049–1056. doi: 10.1111/apt.12075

Table 2.

Demographic characteristics of inflammatory bowel disease immunomodulator users

Number
(%)		 WBC within
90 days
(%)		 P-value
Total 6045 56.9
IBD type <0.01
  Crohn’s disease 2882 (48) 55.9
  Ulcerative colitis 2376 (39) 54.0
  Indeterminate colitis 787 (13) 69.3
Race <0.01
  Caucasian 4438 (73) 57.7
  African American 636 (11) 65.6
  Hispanic 185 (3) 60.5
  Other 112 (2) 63.4
  Unknown 674 (11) 41.3
Gender <0.01
  Male 5573 (92) 56.2
  Female 472 (8) 64.6
Age at IMM index <0.01
  <35 816 (14) 62.0
  35–49 1164 (19) 60.7
  50–64 2372 (39) 61.3
  65+ 1693 (28) 45.5